Ubs Group Ag Renovo Rx, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 12,266 shares of RNXT stock, worth $12,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,266
Previous 2,236
448.57%
Holding current value
$12,756
Previous $2,000
750.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RNXT
# of Institutions
20Shares Held
1.97MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.01 Million0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA236KShares$245,1770.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX197KShares$205,1400.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$147,1460.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$101,0510.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.43M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...